0.0418SEK+7.18%Mkt Cap: 19.17M SEKP/E: —Last update: 2026-05-13
Gabather AB (publ), a pharmaceutical company, develops drug candidates for the treatment of central nervous system diseases. The company offers drugs primarily in the areas of anti-psychotics, anti-depressants and anxiol…
Industry Peers
Drug Manufacturers - Specialty & Generic153.14BSEKP/E 167.7
58.14BTRYP/E 27.8
51.02BEURP/E 20.1
13.68BEURP/E 31.2
13.35BTRY—
13.10BSEKP/E 39.5
3.09BTRY—
3.02BEURP/E 25.0
loading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
P/B19.50
P/S—
EV/EBITDA—
EV/Revenue—
EPS (TTM)-0.02
EPS (Forward)—
Cash Flow & Leverage
FCF Yield-20.62%
FCF Margin—
Operating CF-7.22M SEK
CapEx (TTM)—
Net Debt/EBITDA—
Net Debt-3.14M SEK
Technical
SMA 500.0435 (-4.0%)
SMA 2000.0361 (+15.7%)
Beta-0.71
S&P 52W Chg24.23%
Avg Vol (30d)5.51M
Avg Vol (10d)3.99M
Technical Indicators
RSI (14)52.9
MACD-0.0002
MACD Signal-0.0007
MACD Hist.+0.0005
BB Upper0.0440 SEK
BB Middle0.0382 SEK
BB Lower0.0324 SEK
BB Width30.46%
ATR (14)0.0075 SEK
Vol Ratio (20d)0.16x
52W Range
0.023018% of range0.1300
52W High0.1300 SEK
52W Low0.0230 SEK
Profitability
Gross Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
Oper. Margin0.00%
ROE-702.72%
ROA-86.87%
Revenue Growth—
Earnings Growth—
Balance Sheet
Debt/Equity—
Current Ratio0.81
Quick Ratio0.77
Book Value/Sh0.0020 SEK
Cash/Share0.0060 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:4
Split DateMar 22, 2018
Ownership
Shares Out.491.63M
Float—
Insiders11.24%
Institutions4.49%
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Company
Market Cap19.17M SEK
Enterprise Value16.03M SEK
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-4.65M SEK
Revenue/Share—
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees—
Last Price0.0418 SEK
CountrySE
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINSE0010869552